Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. ...
Q1 2026
May 28, 2026
FY 2025
Mar 24, 2026
Q4 2025
Q3 2025
Nov 14, 2025
Q2 2025
Aug 15, 2025